HCA(US:HCA)2026-01-27 12:12Financial Performance - Revenues for Q4 2025 totaled $19.513 billion, a 6.7% increase from $18.285 billion in Q4 2024[3] - Net income attributable to HCA Healthcare, Inc. rose 30.6% to $1.878 billion, or $8.14 per diluted share, compared to $1.438 billion, or $5.63 per diluted share, in Q4 2024[5] - Adjusted EBITDA for Q4 2025 was $4.114 billion, reflecting a 10.8% increase from $3.712 billion in Q4 2024[4] - For the year ended December 31, 2025, revenues totaled $75.600 billion, up from $70.603 billion in 2024[8] - Net income for the year 2025 was $7,782 million, representing a 16.9% increase from $6,657 million in 2024[24] - Comprehensive income attributable to HCA Healthcare, Inc. for 2025 was $6,866 million, compared to $5,798 million in 2024[24] - Total revenues for the year ended December 31, 2025, were $75,600 million, a 7.1% increase from $70,603 million in 2024[24] Cash Flow and Assets - Cash flows from operating activities in Q4 2025 were $2.359 billion, down from $2.559 billion in Q4 2024[10] - Cash and cash equivalents at the end of Q4 2025 were $1,040 million, down from $1,933 million at the end of Q4 2024[26] - Net cash provided by operating activities for 2025 was $12,636 million, an increase from $10,514 million in 2024[27] - Total assets as of December 31, 2025, were $60,720 million, compared to $59,513 million at the end of 2024[26] - Long-term debt as of December 31, 2025, was $41,603 million, an increase from $38,333 million at the end of 2024[26] Future Projections - The company expects 2026 revenues to range from $76.500 billion to $80.000 billion[15] - The estimated net income for 2026 is projected to be between $6.495 billion and $7.035 billion[15] - Adjusted EBITDA for 2026 is forecasted to be between $15,550 million and $16,450 million[36] - The forecast for revenues in 2026 is between $76,500 million and $80,000 million[36] - Projected net income attributable to HCA Healthcare, Inc. for 2026 is estimated to be between $6,495 million and $7,035 million[36] Operational Metrics - Same facility admissions increased by 2.4% and same facility equivalent admissions increased by 2.5% in Q4 2025 compared to the prior year[7] - Total admissions for Q4 2025 were 576,839, a 3.2% increase from 559,170 in Q4 2024[32] - Revenue per equivalent admission increased to $18,794 in Q4 2025, up 3.6% from $18,146 in Q4 2024[32] - The average length of stay decreased slightly to 4.696 days in Q4 2025 from 4.814 days in Q4 2024[32] - The number of hospitals remained stable at 190, with licensed beds increasing to 50,436 by the end of 2025[29] Shareholder Returns - HCA Healthcare's Board of Directors declared a quarterly cash dividend of $0.78 per share, payable on March 31, 2026[13] - The company authorized an additional share repurchase program for up to $10 billion of its outstanding common stock[12]